| Product Code: ETC070085 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Jordan Biobanking Market was estimated at USD 554 Million in 2025 and is projected to reach USD 788 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This upward trajectory is fueled by increased investments in healthcare infrastructure and a heightened focus on personalized medicine. Furthermore, advancements in technology are enhancing biobanking processes, allowing for better sample management and data integration.
The Jordan biobanking market has demonstrated stable growth, with annual increases ranging from 5.7% to 6.4% over the next decade. Beginning with a growth rate of 6.1% in 2021, the market maintained strong performance at 6.0% in 2022 and 2023. However, growth is projected to accelerate slightly to 6.3% in 2024, fueled by rising investments in healthcare infrastructure and advancements in biotechnology. As the sector matures, it may experience slight fluctuations, notably dipping to 5.7% in 2026 due to market saturation and competitive pressures. Nonetheless, projected growth of 6.4% by 2031 highlights the enduring demand for biobanking services, driven by technological innovations and evolving consumer needs in health management.
This graph highlights how the Jordan Biobanking Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 6.1% | Increasing adoption of advanced technologies |
| 2022 | 6.0% | Increasing industrial infrastructure investments |
| 2023 | 6.0% | Increasing industrial infrastructure investments |
| 2024 | 6.3% | Increasing industrial automation investments |
| 2025 | 6.2% | Increasing industrial infrastructure investments |
| 2026 | 5.7% | Growing urbanization and commercial development |
| 2027 | 5.9% | Increasing industrial automation investments |
| 2028 | 6.0% | Growing renewable energy integration projects |
| 2029 | 6.0% | Increasing smart city development projects |
| 2030 | 6.1% | Increasing adoption of advanced technologies |
| 2031 | 6.4% | Expansion of manufacturing activities |
| 2032 | 5.9% | Expansion of transportation and logistics networks |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The recent momentum in the Jordan biobanking market signals a vital shift towards advanced medical research and personalized healthcare. As research activities gain traction, the role of biobanks in collecting, storing, and managing biological samples becomes increasingly critical.
Looking forward, the market is set to benefit from collaborative initiatives between academic institutions and healthcare providers. These partnerships are expected to bolster data sharing and drive innovation in biobanking practices, ensuring a brighter future for the sector.
Despite the promising outlook, several real restraints hinder the growth of the Jordan biobanking market. A significant issue is the lack of standardized regulations and guidelines, which can impact sample quality and data integrity. Moreover, the shortage of trained professionals experienced in biobanking processes creates operational inefficiencies. To unlock the full potential of this market, addressing these challenges through improved training and regulatory frameworks will be essential.
Current trends in the Jordan biobanking market are largely shaped by the increasing focus on personalized and precision medicine. These developments are creating a robust demand for high-quality biological samples that are essential for groundbreaking research. In addition, the integration of automated systems and digitized processes is not only enhancing efficiency but also improving tracking and management of samples.
The rise in collaborative efforts between biobanks, research institutions, and healthcare providers is another notable trend. This shift is facilitating the sharing of resources and knowledge, thus accelerating innovation in biobanking practices.
The Jordan biobanking market offers a multitude of investment opportunities, especially in the context of rising interest in personalized medicine and genomic research. Investors may consider funding partnerships with biobanks that are focused on supporting high-quality biological sample collections. Additionally, there is potential for growth by investing in modern biobanking technologies that can enhance operational capabilities and streamline research efforts, positioning stakeholders to capitalize on the expanding healthcare landscape.
The Jordanian government has been proactive in promoting the biobanking sector through comprehensive policies and initiatives. Guidelines have been established to ensure ethical practices in the collection, storage, and use of biological samples. Furthermore, governmental support for collaborations between research institutions and biobanks is fostering a conducive environment for innovation. Investments in healthcare research projects underline the commitment to advancing biobanking as a cornerstone of precision medicine.
Looking ahead, the Jordan biobanking market is expected to maintain a steady growth trajectory, driven by ongoing investments in healthcare infrastructure. The demand for personalized and precision medicine is anticipated to grow, necessitating the development of large-scale biobanks to facilitate extensive medical research and drug development. Collaborative efforts involving academic institutions, government bodies, and private sectors are likely to enhance biobanking capabilities and promote sustainable growth in this pivotal industry.
Recent developments in the Jordan biobanking market indicate a surge in collaborative projects aimed at enhancing the sharing of biological data. Additionally, various biobanks have started implementing state-of-the-art biobanking technologies to improve sample management and tracking efficiency. As the sector evolves, educational initiatives aimed at training professionals in biobanking processes are also gaining traction, paving the way for more robust operations.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Biobanking Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 Jordan Biobanking Market - Industry Life Cycle |
3.4 Jordan Biobanking Market - Porter's Five Forces |
3.5 Jordan Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Jordan Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Jordan Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 Jordan Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Jordan Biobanking Market Trends |
6 Jordan Biobanking Market, By Types |
6.1 Jordan Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Jordan Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 Jordan Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 Jordan Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 Jordan Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 Jordan Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Jordan Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 Jordan Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 Jordan Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 Jordan Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Jordan Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 Jordan Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 Jordan Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 Jordan Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 Jordan Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 Jordan Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 Jordan Biobanking Market Import-Export Trade Statistics |
7.1 Jordan Biobanking Market Export to Major Countries |
7.2 Jordan Biobanking Market Imports from Major Countries |
8 Jordan Biobanking Market Key Performance Indicators |
9 Jordan Biobanking Market - Opportunity Assessment |
9.1 Jordan Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Jordan Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Jordan Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 Jordan Biobanking Market - Competitive Landscape |
10.1 Jordan Biobanking Market Revenue Share, By Companies, 2025 |
10.2 Jordan Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here